Diabetic retinopathy (DR) is a common chronic complication of diabetes mellitus. Endothelin-1 (ET-1) has been identified as a key regulator of various ocular functions, including vascular perfusion, ...

The treatment of diabetic retinopathy (DR) and diabetic macular edema (DME) has evolved significantly since the introduction of first effective treatments 50 years ago. Like with any disease, ...

Individuals with type 2 diabetes — with or without retinopathy — had higher risks for incident Alzheimer’s disease and dementia than those without the blood sugar disorder. Among patients with ...

The saliva circulating in your mouth contains troves of microbial information about the rest of your body and is easier to collect than blood samples. Today, a few drops of spit can help detect ...

Quadrant-specific changes in superficial vascular complex vessel density, particularly in the 16- to 21-mm temporal region, are potential early biomarkers for diabetic retinopathy. Widefield ...

In research published in the journal Gut, investigators from the University of Alabama at Birmingham report that restoring tryptophan metabolism in the gut microbiome can prevent or reverse diabetic ...

A higher incidence of new diabetic retinopathy has previously been reported in patients using GLP-1 receptor agonists. A new retrospective study suggested that use of tirzepatide was tied to a reduced ...

Previous studies have shown conflicting results on the relationship between glucagon-like peptide-1 (GLP-1) receptor agonists and diabetic retinopathy (DR). This systematic review and meta-analysis ...

Sun Pharma has launched an eye-opening awareness push about a common—and commonly overlooked—complication of diabetes. The “#SeeBeyondSugar” campaign, which began rolling out amid Nov. 14’s World ...

Ensemble deep-learning system with xAI (Grad-CAM) for automated diabetic retinopathy detection and staging using retinal fundus images.